Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancer. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Burtness B, Thomas L, Sipples R, McGurk M, Salikooti S, Christoforou M, Mirto G, Salem R, Sosa J, Kloss R, Rahman Z, Chung G, Lacy J, Murren JR

Publication

Cancer journal (Sudbury, Mass.)

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1456426

Publication Year

2007

PubMed ID

17762761

Publication Title

Burtness B, Thomas L, Sipples R, McGurk M, Salikooti S, Christoforou M, Mirto G, Salem R, Sosa J, Kloss R, Rahman Z, Chung G, Lacy J, Murren JR. Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancer. Cancer J. 2007 Jul-Aug; 13(4):257-62.